Next-generation sequencing via TruRisk® genepanel reveal high mutation prevalence in additional risk genes in German BRCA1/2-negative breast and ovarian cancer families

被引：0

作者：

Keupp, K. ^{[1
]}

Ernst, C. ^{[1
]}

Bluemcke, B. ^{[1
]}

Versmold, B. ^{[1
]}

Waha, A. ^{[1
]}

Driesen, J. ^{[1
]}

Baasner, A. ^{[1
]}

Larsen, M. ^{[1
]}

Buelow, L. ^{[1
]}

Kroeber, S. ^{[1
]}

Altmueller, J. ^{[2
]}

Thiele, H. ^{[2
]}

Nuernberg, P. ^{[2
]}

Wappenschmidt, B. ^{[1
]}

Neidhardt, G. ^{[1
]}

Rhiem, K. ^{[1
]}

Schmutzler, R. ^{[1
]}

Hahnen, E. ^{[1
]}

Hauke, J. ^{[1
]}

机构：

[1] Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany

[2] CCG, Cologne, Germany

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2018年 / 26卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P12.058B

引用

页码：541 / 542

页数：2

共 50 条

[41] Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
Hannaleena Eerola
Eero Pukkala
Seppo Pyrhönen
Carl Blomqvist
Risto Sankila
Heli Nevanlinna
[J]. Cancer Causes & Control, 2001, 12 : 739 - 746
[42] BRCA1 mutation analysis in 27 cypriot families with high risk of hereditary breast and ovarian cancer
Hadjisavvas, A
Adamou, A
Kyriacou, KC
Christodoulou, C
[J]. DISEASE MARKERS, 1999, 15 (1-3) : 98 - 98
[43] Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases
Koczkowska, Magdalena
Zuk, Monika
Gorczynski, Adam
Ratajska, Magdalena
Lewandowska, Marzena
Biernat, Wojciech
Limon, Janusz
Wasag, Bartosz
[J]. CANCER MEDICINE, 2016, 5 (07): : 1640 - 1646
[44] Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer
Maxwell, Kara N.
Wubbenhorst, Bradley
D'Andrea, Kurt
Garman, Bradley
Long, Jessica M.
Powers, Jacquelyn
Rathbun, Katherine
Stopfer, Jill E.
Zhu, Jiajun
Bradbury, Angela R.
Simon, Michael S.
DeMichele, Angela
Domchek, Susan M.
Nathanson, Katherine L.
[J]. GENETICS IN MEDICINE, 2015, 17 (08) : 630 - 638
[45] Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2
Beristain E.
Ibáñez B.
Vergara I.
Martínez-Bouzas C.
Guerra I.
Tejada M.I.
[J]. Journal of Community Genetics, 2010, 1 (2) : 91 - 99
[46] Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history
Salmi, Fatiha
Maachi, Fatima
Tazzite, Amal
Aboutaib, Rachid
Fekkak, Jamal
Azeddoug, Houssine
Jouhadi, Hassan
[J]. PLOS ONE, 2021, 16 (07):
[47] BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families
Berzina, Dace
Nakazawa-Miklasevica, Miki
Zestkova, Jekaterina
Aksenoka, Karina
Irmejs, Arvids
Gardovskis, Andris
Kalniete, Dagnija
Gardovskis, Janis
Miklasevics, Edvins
[J]. BMC MEDICAL GENETICS, 2013, 14
[48] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
S. L. Harvey
R. L. Milne
S. A. McLachlan
M. L. Friedlander
K. E. Birch
P. Weideman
D. Goldgar
J. L. Hopper
K. A. Phillips
[J]. Breast Cancer Research and Treatment, 2011, 130 : 1057 - 1061
[49] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
Harvey, S. L.
Milne, R. L.
McLachlan, S. A.
Friedlander, M. L.
Birch, K. E.
Weideman, P.
Goldgar, D.
Hopper, J. L.
Phillips, K. A.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1057 - 1061
[50] High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer
Grzybowska, E
Zientek, H
Jasinska, A
Rusin, M
Kozlowski, P
Sobczak, K
Sikorska, A
Kwiatkowska, E
Gorniak , L
Kalinowska, E
Utracka-Hutka, B
Wloch, J
Chmielik, E
Krzyzosiak, WJ
[J]. HUMAN MUTATION, 2000, 16 (06) : 482 - 490

← 1 2 3 4 5 →